UK IBD market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. IBD is one of the key chronic inflammatory digestive diseases prevalent in the country. The disease is caused by a number of factors including the changing lifestyle of the population, the prevalence of Crohn's disease in the country are a few of the key reasons which are expected to promote the demand of treatment and diagnostic services for IBD. The research on autoimmune diseases has gained momentum in the UK. Although the inflammatory and immune diseases register only a small portion in the research funding by the public, it is expected to increase in the coming years. For instance, the department of health’ National Institute of health research allocated a budget of $52.6 million in 2014-2015 for research on inflammatory and immune diseases. This budget also included research on inflammatory diseases in the country. On similar lines, the medical research council also contributed $44.4 million for research on immunology. As these research funding increase in the coming years so as to decrease the mortality rate due to these chronic diseases, it is expected to further increase the opportunities for the market in the near future.

Request a Free Sample of our UK Inflammatory Bowel Disease (IBD) Market: https://www.omrglobal.com/request-sample/uk-ibd-inflammatory-bowel-disease-market

UK IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. UK IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market is segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

A full Report of UK Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/uk-ibd-inflammatory-bowel-disease-market

UK Inflammatory Bowel Disease IBD Market Segmentation

By Disease Type

• Ulcerative Colitis
• Crohn’s Disease
• UK IBD Market by Diagnostics
• Blood and Stool Tests
• Endoscopies,
• Ultrasound
• X-Ray
• UK IBD Market by Therapeutics
• Surgery
• Anti- Inflammatory Drug Administration
• Steroids
• Immunosuppressant
• Biological Drugs
• Amino salicylates
• Others

Company Profiles

• AbbVie Inc.
• Allergan, PLC
• Boehringer Ingelheim International GmbH
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Pfizer Inc.
• Pharmacosmos A/S
• Sanofi S.A.
• Takeda pharmaceutical Co., Ltd.
• UCB, Inc.
• Vifor Pharma Group

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-ibd-inflammatory-bowel-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404